The impact of coadministration of venlafaxine, citalopram or gabapentin on the metabolic activation of tamoxifen.
Saved in:
| Title: | The impact of coadministration of venlafaxine, citalopram or gabapentin on the metabolic activation of tamoxifen. |
|---|---|
| Authors: | Safgren SL; Department of Oncology, Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA., Suman VJ; Division of Quantitative Health Sciences, Department of Health Sciences, Mayo Clinic, Rochester, MN, USA., Leon Ferre RA; Department of Oncology, Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA., Kosel ML; Division of Quantitative Health Sciences, Department of Health Sciences, Mayo Clinic, Rochester, MN, USA., Stearns V; Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA., Henry NL; Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA., Denduluri N; AstraZeneca, Arlington, VA, USA., Irvin W; Bon Secours Mercy Health, Bon Secours Cancer Institute, Midlothian, VA, USA., Ingle JN; Department of Oncology, Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA., Sideras K; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, USA., Ames MM; Department of Oncology, Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA., Reid JM; Department of Oncology, Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA.; Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA., Loprinzi CL; Department of Oncology, Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA., Black JL; Division of Laboratory Genetics and Genomics, Personalized Genomics Laboratory, Mayo Clinic Laboratories, Mayo Clinic, Rochester, MN, USA., Weinshilboum RM; Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA., Goetz MP; Department of Oncology, Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA. Goetz.Matthew@mayo.edu. |
| Source: | Breast cancer research and treatment [Breast Cancer Res Treat] 2025 May; Vol. 211 (1), pp. 261-270. Date of Electronic Publication: 2025 Feb 27. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1573-7217 |
|---|---|
| DOI: | 10.1007/s10549-025-07644-3 |
